Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Universal Health Services (7.3) and Alnylam Pharmaceuticals (7.5). Figures as of 20 Nov 2026, 01:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.2
- Combined market value
- SGD 11.52T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | LifeStance Health GroupLFST · Health Care | 74.1 | SGD 6.5B | SGD 17.23 | 3.12% down | 123% up | ||
| 102 | ICONICLR · Health Care | 76.1 | SGD 18.4B | SGD 245.81 | 2.46% down | 23% up | ||
| 103 | TeleflexTFX · Health Care | 80.5 | SGD 8.4B | SGD 210.99 | 1.48% down | 58% up | ||
| 104 | PenumbraPEN · Health Care | 80.6 | SGD 16.3B | SGD 413.22 | 0.18% down | 15% up | ||
| 105 | MedlineMDLN · Health Care | 86.0 | SGD 64.3B | SGD 48.86 | 3.37% down | 4% down | ||
| 106 | Teva Pharmaceutical IndustriesTEVA · Health Care | 89.6 | SGD 58.1B | SGD 49.77 | 8.74% down | 74% up | ||
| 107 | SolventumSOLV · Health Care | 96.4 | SGD 18.8B | SGD 110.79 | 0.79% down | 9% up | ||
| 108 | TG TherapeuticsTGTX · Health Care | 96.8 | SGD 12.7B | SGD 83.78 | 1.88% down | 117% up | ||
| 109 | BillionToOneBLLN · Health Care | 98.0 | SGD 5.6B | SGD 116.47 | 1.46% down | 4% down | ||
| 110 | BiogenBIIB · Health Care | 107 | SGD 47.2B | SGD 319.11 | 1.70% down | 49% up | ||
| 111 | Ligand PharmaceuticalsLGND · Health Care | 115 | SGD 7.4B | SGD 370.52 | 3.94% down | 50% up | ||
| 112 | Merck & CoMRK · Health Care | 134 | SGD 422.8B | SGD 171.49 | 3.61% down | 45% up | ||
| 113 | WatersWAT · Health Care | 191 | SGD 115.8B | SGD 589.44 | 2.06% down | 23% up | ||
| 114 | Takeda PharmaceuticalTAK · Health Care | 306 | SGD 88.3B | SGD 27.65 | 0.66% up | 51% up | ||
| 115 | Charles River Laboratories InternationalCRL · Health Care | 356 | SGD 20.3B | SGD 423.45 | 1.60% down | 106% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2913 SGD). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Universal Health Services (7.3) and Alnylam Pharmaceuticals (7.5) have the lowest P/E ratio of the 115 health care companies ranked here as of 20 Nov 2026, 01:12 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SGD 11.52T as of 20 Nov 2026, 01:12 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.